Importantly, these enhanced tumorigenic phenotypes can be reversed by overexpression of PPM1B. Our findings provide the mechanistic bases for functional loss of RBM10 in promoting tumorigenicity, and are potentially useful in the development of combined therapeutic strategies for cancer patients with defective RBM10.
2 years ago
Journal
|
RBM10 (RNA Binding Motif Protein 10) • YBX1 (Y-Box Binding Protein 1) • PPM1B (Protein Phosphatase, Mg2+/Mn2+ Dependent 1B)